Because of the life threatening Prempro side effects, Prempro class actions suits have been filed and the Food and Drug Administration (FDA) and Wyeth have revised the prescribing information to include a boxed warning stating that estrogens and estrogens plus progestin should not be used for the prevention of heart disease.
The Prempro class action allegations rely on the fact that the boxed warning now includes risk information from the Women’s Health Initiative (WHI) study about increased risks of Prempro side effects of heart attacks, stroke, invasive breast cancer, pulmonary embolism (blood clots), and deep vein thrombosis in postmenopausal women. Estrogens with or without progestin should be prescribed at the lowest effective doses and for the shortest duration.
Do you qualify for the Prempro class action suit? On July 11, 2002, a nationwide Prempro class action lawsuit was filed on behalf of all women who were prescribed Prempro. As alleged in the Prempro class action lawsuit, Wyeth and Wyeth-Ayerst Research were named as the defendants in this action due to their responsibility in manufacturing, promoting, marketing, distributing, and selling Prempro. The Prempro class action lawsuit wants to inform the public that Prempro consumers are at an increased risk of harmful Prempro side effects and/or death. The Prempro class action lawsuit seeks to establish a medical monitoring fund so that all women who took Prempro or are still taking Prempro may be tested and treated for its adverse effects. The Prempro class action lawsuit wants to reimburse monies paid for the product to provide compensation to all victims for personal injuries and death caused from Prempro side effects.
Monheit Law is investigating Prempro Cancer cases for long term users of Prempro who have developed either breast or ovarian cancer.
See: http://www.monheit.com/prempro/being_done.shtml
